Cellectis (CLLS) EPS (Weighted Average and Diluted) (2016 - 2023)
Historic EPS (Weighted Average and Diluted) for Cellectis (CLLS) over the last 4 years, with Q2 2021 value amounting to -$34.12.
- Cellectis' EPS (Weighted Average and Diluted) rose 1962.84% to -$34.12 in Q2 2021 from the same period last year, while for Jun 2021 it was -$34.12, marking a year-over-year increase of 1962.84%. This contributed to the annual value of -$2.33 for FY2022, which is 862.75% up from last year.
- Per Cellectis' latest filing, its EPS (Weighted Average and Diluted) stood at -$34.12 for Q2 2021, which was up 1962.84% from -$42.45 recorded in Q2 2020.
- Over the past 5 years, Cellectis' EPS (Weighted Average and Diluted) peaked at -$29.08 during Q2 2019, and registered a low of -$42.45 during Q2 2020.
- Over the past 3 years, Cellectis' median EPS (Weighted Average and Diluted) value was -$34.12 (recorded in 2021), while the average stood at -$35.22.
- Per our database at Business Quant, Cellectis' EPS (Weighted Average and Diluted) tumbled by 4595.93% in 2020 and then skyrocketed by 1962.84% in 2021.
- Quarter analysis of 3 years shows Cellectis' EPS (Weighted Average and Diluted) stood at -$29.08 in 2019, then plummeted by 45.96% to -$42.45 in 2020, then grew by 19.63% to -$34.12 in 2021.
- Its EPS (Weighted Average and Diluted) stands at -$34.12 for Q2 2021, versus -$42.45 for Q2 2020 and -$29.08 for Q2 2019.